Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - PA: CIHR/Rx&D - CAMO Research Program

Direct Payment

$37,501.00

Clinical and translational studies of hypoxia in Squamous Cell Carcinoma of the Head and Neck

FY 2008-09

Summary
Oxygen deficiency (hypoxia) is a common characteristic found in squamous cell carcinoma of the head and neck (SCCHN). In this tumour type, hypoxia has been shown to contribute to increased resistance to radiation treatment. Understanding the mechanisms that lead to tumour hypoxia may uncover effective ways of delivering treatment with chemotherapy, biologic agents, and radiation to patients with SCCHN. The prognosis of SCCHN has been shown to be worse with the expression of a cell membrane receptor named the Epidermal Growth Factor Receptor (EGFR). Conversely, the presence of human papilloma virus (HPV) is a favourable prognostic factor for SCC of the oropharynx. This study will firstly investigate whether tumour hypoxia, measured with specialized PET scans, is associated with the expression of the EGFR protein and EGFR gene copy number, and with HPV expression on tumour specimens. Secondly, we plan on studying the effect that treatment with an EGFR inhibitor (panitumamab) or chemotherapy with docetaxel, cisplatin, and 5-fluorouracil has on tumour hypoxia, again through using specialized functional imaging. By improving our understanding of factors that are associated with tumour hypoxia, and interventions that affect tumour hypoxia, this study may assist in developing more effective treatment for patients with SCCHN.
Program
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Location
Victoria, Australia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
178339
Name
Trinkaus Mateya E
Region
Victoria
Country
Australia
Orgtype
Research Institution
Partnername
Canadian Association of Medical Oncologists (Ottawa)
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Clinical and translational studies of hypoxia in Squamous Cell Carcinoma of the Head and Neck
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$37,501
Cihrequipment2
$0
Programname2
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Keyworddelim
Functional Imaging; Head And Neck Cancer; Hypoxia; Translational Research
Abstract
Oxygen deficiency (hypoxia) is a common characteristic found in squamous cell carcinoma of the head and neck (SCCHN). In this tumour type, hypoxia has been shown to contribute to increased resistance to radiation treatment. Understanding the mechanisms that lead to tumour hypoxia may uncover effective ways of delivering treatment with chemotherapy, biologic agents, and radiation to patients with SCCHN. The prognosis of SCCHN has been shown to be worse with the expression of a cell membrane receptor named the Epidermal Growth Factor Receptor (EGFR). Conversely, the presence of human papilloma virus (HPV) is a favourable prognostic factor for SCC of the oropharynx. This study will firstly investigate whether tumour hypoxia, measured with specialized PET scans, is associated with the expression of the EGFR protein and EGFR gene copy number, and with HPV expression on tumour specimens. Secondly, we plan on studying the effect that treatment with an EGFR inhibitor (panitumamab) or chemotherapy with docetaxel, cisplatin, and 5-fluorouracil has on tumour hypoxia, again through using specialized functional imaging. By improving our understanding of factors that are associated with tumour hypoxia, and interventions that affect tumour hypoxia, this study may assist in developing more effective treatment for patients with SCCHN.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Trinkaus, Mateya E
Approvedterm
1 an 0 mois
Cihrcontribution2
Patient Oriented Research~ $37,501~ $0~